Sale

Recombinant Protein Market

Global Recombinant Protein Market Size, Share, Forecast: By Product Type: Growth Factor and Cytokines, Hormone, Enzyme, Antibody, Immune Checkpoint Proteins, Recombinant Regulatory Proteins, Others; By Application: Therapeutic, Research, Biotechnology Industry; Regional Analysis; Supplier Landscape; 2024-2032

Global Recombinant Protein Market Size

The global recombinant protein market was valued at USD 1.9 billion in 2023, driven by the increasing demand for effective drugs to treat chronic diseases across the globe. The market is expected to grow at a CAGR of 11.21% during the forecast period of 2024 and 2032, likely to attain a value of USD 5 billion by 2032.

 

recombinant protein market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Recombinant Protein Market Outlook

  • The market growth is expected to grow in value due to the increasing demand for effective and efficient drugs for improved treatment of patients. The development of such drugs has been sped up due to the creation of various effective recombinant protein-based vaccines created for COVID-19.
  • The rising prevalence of chronic illness is likely to enhance the demand for recombinant protein therapies due to their effectiveness in treating such diseases. The market is expected to expand further with the growing number of cancer cases.
  • With the rising demand for effective drugs for specific diseases, key players and government agencies are increasingly investing in the development of novel drugs, which is expected to propel the market development further.

 

Global Recombinant Protein Market Overview

Recombinant proteins are synthesized using recombinant DNA methods, where a new gene sequence is produced and the coded protein is inserted into host organism such as bacteria, yeast, or animal cells to produce the protein. It involves gene cloning and transformation. It enables selection, expression, purification and study of the protein. Recombinant proteins are vital in medicine (for instance, insulin and monoclonal antibodies), research, industry, and agriculture because their quality is standardized, the expression level can be easily scaled up and fine-tuned according to the needs. In addition, the production can be customized depending on the specific application. It offers advantages like purity and offers advantages like cost efficiency, making it ideal for mass production.

 

Global Recombinant Protein Market Growth Drivers

Increased Application in Disease Management

Diseases like cerebral apoplexy, multiple sclerosis, neutropenia, and thrombocytopenia are becoming more common, boosting the demand for recombinant proteins. Cancer is a highly common and fast-growing chronic disease among the major chronic diseases. The American Cancer Society (ACS) analysis from 2023 projected 1,958,310 and 609,820 deaths in United States, requiring effective and precise treatment alternatives to combat the condition. Recombinant proteins are also used in the treatments like such as chemotherapy, cell culture, western blot, animal cell culture, glycosylation, biotherapeutic products, and bioengineering, thereby, boosting the global market value.

 

Surge in Partnerships Between Leading Players to Meet Rising Recombinant Protein Market Demand

In January 2024, Nucleus Biologics, a top cell culture media provider, entered a deal with Core Biogenesis to distribute and manufacture affordable and sustainable recombinant proteins. Together, the two companies aim to work together and deliver better, cheaper reagents and media to the cell and gene therapy markets. As per the terms of agreement, Nucleus Biologics will act as a GMP manufacturer for Core Biogenesis’ recombinant proteins. Such partnerships are expected to shape the market landscape effectively, as it works to provide precise and affordable solutions to consumers.

 

recombinant protein market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Recombinant Protein Market Trends

Key Trends Impact
Focus on Personalized Medicine The use of recombinant proteins is evolving the treatment of patients, along with the possibility of creating unique therapies. These proteins are critical in developing therapies based on genetic makeup, notably in cancer and inherited metabolic diseases. The special accuracy of recombinant proteins in such applications is not only more effective in the treatment of disease but also decreases the side effects of the therapy, making it safer and more effective.
Adoption of Agricultural Biotechnology These recombinant proteins are used in agricultural biotechnology as well. These proteins play a significant role in creating desirable transgenic crops characterized by resistance to pests, diseases, and drought, besides boosting their nutritional value. Recombinant proteins are also playing a role in the development of bio-pesticides and bio-fertilizers for sustainable agriculture and raising crop productivity.
Increased Collaborations and Partnerships Strategic collaborations and partnerships assuming greater significance in the recombinant protein market, intended to foster innovation. The biotechnology firms are collaborating to capitalize on synergistic capabilities, exchange new technologies, and accelerate development programs. They provide new access to markets, research, and development relief, as well as innovation.

 

Global Recombinant Protein Market Segmentation

Market Breakup by Product Type

  • Growth Factor and Cytokines
  • Hormone
  • Enzyme
  • Antibody
  • Immune Checkpoint Proteins
  • Recombinant Regulatory Proteins
  • Others

 

Market Breakup by Application

  • Therapeutic
  • Research
  • Biotechnology Industry

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Recombinant Protein Market Share

Hormones Lead the Market Based on Product Type

Based on product type, the market can be divided into growth factor and cytokines, hormones, enzymes, antibodies, immune checkpoint proteins, and recombinant regulatory proteins, among others. The hormones segment is likely to take lead, owing to its versatility, particularly in the areas of research and innovation, including the development of therapies for diseases including diabetes. Hormones are very essential in the body involved in treatment for various diseases. Moreover, ease of intake makes it a popular alternative amongst users, affecting the market dynamics significantly.

 

Biotechnology Industry is Anticipated to Have Largest Market Share Based on Application

Based on application, the market is divided into therapeutic, research, biotechnology Industry. Among these biotechnology industry is expected to hold a significant market share, as it widely applies recombinant proteins at the clinical stages of designing, testing, and manufacturing new drugs. Recombinant proteins are central to the development of biopharmaceuticals and translate research successes into production that is clinically scalable.

 

recombinant protein market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Recombinant Protein Market Analysis by Region

Various regions covered in the global market report include North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Based on the regional analysis, North America is projected to hold largest market share in the forecast period, driven by increasing prevalence of diseases like cancer, diabetes, cardiovascular diseases, chronic respiratory diseases, among others. Growth in research and development activities between key market stakeholders and governments to meet the rising need for efficient medicine and treatment is also play a critical role in boosting market value.

 

The Asia Pacific region is likely to grow at a faster rate, owing to factors such as increasing healthcare expenditure, the growing biotechnology sector, and the upsurge in interest in recombinant protein therapies. For instance, in May 2023, Thermo Fisher Scientific Inc., and National Research and Innovation Agency (BRIN) entered the Memorandum of Understanding (MOU) with the aim of strengthening the Indonesian research and innovation systems and capacities. The partnership was aimed at helping and supporting country-level research and innovation institutions and their capacities towards improving scientific activity and the Indonesian economy. The collaboration can be viewed as a move towards enhancing the capacity of Indonesia to contribute and advance in the global realm of research and innovation.

 

Leading Players in the Global Recombinant Protein Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis along with strategic initiatives by the key players. The major companies in the market are as follows:

 

Abcam PLC

Founded in 1998, this company occupies a premier position in the market dealing in protein research tools. The specific areas of expertise crafted by the company include primary antibodies and secondary antibodies, proteins and peptides, knockout cell lines and lysates, and cell and tissue imaging reagents, among others.

 

Thermo Fisher Scientific, Inc.,

Known as one of the largest biotechnology research companies, it is based in Massachusetts, United States. The company operates in different sectors, which include analytical instruments, lab supply chain services and e-business solutions, general lab equipment and services, specialty diagnostics, life science records, pharma solutions, contract development, and manufacturing organization.

 

Bio-Techne Corp.

This United States based company is a provider of purified proteins and reagent solutions to customers in pharmaceuticals and other specialty markets. It is also involved in protein analysis solutions, like analyzing solutions services and produces antibodies, enzymes, proteins, cell culture reagents, and others.

 

F. Hoffmann-La Roche Ltd.

F. Hoffmann-La Roche Ltd. is a leading global pharmaceutical firm with a functional base in Basel, Switzerland; the firm operates in recombinant proteins, among many others. It works in different therapeutic segments, which include oncology, immunology, and infectious disease.

 

Other companies in the market include Abbott, Merck KGaA, Bio-Rad Laboratories, Inc., GeneTex, Inc, Lonza Group SA, PerkinElmer Inc., Sino Biological Inc., TAKARA HOLDINGS INC., Tosoh Corporation, XENOTECH AI Pvt Ltd., and NEW ENGLAND BIOLABS, INC.

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product Type
  • Application
  • Region
Breakup by Product Type
  • Growth Factor and Cytokines
  • Hormone
  • Enzyme
  • Antibody
  • Immune Checkpoint Proteins
  • Recombinant Regulatory Proteins
  • Others
Breakup by Application
  • Therapeutic
  • Research
  • Biotechnology Industry
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Abbott
  • Abcam PLC 
  • Thermo Fisher Scientific, Inc
  • Bio-Techne Corp.
  • Merck KGaA 
  • Bio-Rad Laboratories, Inc.
  • GeneTex, Inc
  • Lonza Group SA 
  • F. Hoffmann-La Roche Ltd.
  • PerkinElmer Inc.
  • Sino Biological Inc.
  • TAKARA HOLDINGS INC.
  • Tosoh Corporation
  • XENOTECH AI Pvt Ltd.
  • NEW ENGLAND BIOLABS, INC 

 

Key Questions Answered in the Recombinant Protein Market Report

  • What was the global recombinant protein market value in 2023?
  • What is the global recombinant protein market forecast outlook for 2024-2032?
  • What are the regional markets covered in the EMR report?
  • What is the market segmentation based on product types?
  • What is the market breakup based on application?
  • What are the major factors aiding the global recombinant protein market demand? 
  • What are the market's major drivers, opportunities, and restraints? 
  • Which regional market is expected to lead the market share in the forecast period? 
  • Which country is expected to experience expedited growth during the forecast period? 
  • What are the major global recombinant protein market trends?
  • How does the rise in the geriatric population impact the market size?
  • Who are the key players involved in the recombinant protein market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers and acquisitions among the key market players shaping the market dynamics?
  • What are the key challenges faced by biotechnology companies in producing recombinant proteins?
  • What factors are driving the growth of the recombinant protein market in North America?
  • What technological advancements are driving innovation in the recombinant protein market?
  • How are global regulatory frameworks affecting the production and distribution of recombinant proteins?

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3     Global Recombinant Protein Market Overview 
    3.1    Global Recombinant Protein Market Historical Value (2017-2023) 
    3.2    Global Recombinant Protein Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    Global Recombinant Protein Market Landscape*
    5.1    Global Recombinant Protein: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2    Global Recombinant Protein: Product Landscape 
        5.2.1    Analysis by Product
        5.2.2    Analysis by Vector
        5.2.3    Analysis Application
        5.2.4    Analysis by Cell type
6    Global Recombinant Protein Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis 
        6.3.1    Political 
        6.3.2    Economic 
        6.3.3    Social 
        6.3.4    Technological 
        6.3.5    Legal 
        6.3.6    Environment
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    Global Recombinant Protein Market Segmentation (2017-2032)
    7.1    Global Recombinant Protein Market (2017-2032) by Product Type
        7.1.1    Market Overview
        7.1.2    Growth Factor and Cytokines
        7.1.3    Hormone
        7.1.4    Enzyme
        7.1.5    Antibody
        7.1.6    Immune Checkpoint Proteins
        7.1.7    Recombinant Regulatory Proteins
        7.1.8    Others
    7.2    Global Recombinant Protein Market (2017-2032) by Application
        7.2.1    Market Overview
        7.2.2    Therapeutic
        7.2.3    Research
        7.2.4    Biotechnology Industry
    7.3    Global Recombinant Protein Market (2017-2032) by Region
        7.3.1    Market Overview
        7.3.2    North America 
        7.3.3    Europe
        7.3.4    Asia Pacific
        7.3.5    Latin America
        7.3.6    Middle East and Africa
8    North America Recombinant Protein Market (2017-2032)
    8.1    North America Recombinant Protein Market (2017-2032) by Product Type
        8.1.1    Market Overview
        8.1.2    Growth Factor and Cytokines
        8.1.3    Hormone
        8.1.4    Enzyme
        8.1.5    Antibody
        8.1.6    Immune Checkpoint Proteins
        8.1.7    Recombinant Regulatory Proteins
        8.1.8    Others
    8.2    North America Recombinant Protein Market (2017-2032) by Application
        8.2.1    Market Overview
        8.2.2    Therapeutic
        8.2.3     Research
        8.2.4    Biotechnology Industry
    8.3    North America Recombinant Protein Market (2017-2032) by Country
        8.3.1    United States of America
        8.3.2    Canada
9    Europe Recombinant Protein Market (2017-2032)
    9.1    Europe Recombinant Protein Market (2017-2032) by Product Type
        9.1.1    Market Overview
        9.1.2    Growth Factor and Cytokines
        9.1.3    Hormone
        9.1.4    Enzyme
        9.1.5    Antibody
        9.1.6    Immune Checkpoint Proteins
        9.1.7    Recombinant Regulatory Proteins
        9.1.8    Others
    9.2    Europe Recombinant Protein Market (2017-2032) by Application
        9.2.1    Market Overview
        9.2.2    Therapeutic
        9.2.3     Research
        9.2.4    Biotechnology Industry
    9.3    Europe Recombinant Protein Market (2017-2032) by Country
        9.3.1    United Kingdom
        9.3.2    Germany
        9.3.3    France
        9.3.4    Italy
        9.3.5    Others
10    Asia Pacific Recombinant Protein Market (2017-2032)
    10.1    Asia Pacific Recombinant Protein Market (2017-2032) by Product Type
        10.1.1    Market Overview
        10.1.2    Growth Factor and Cytokines
        10.1.3    Hormone
        10.1.4    Enzyme
        10.1.5    Antibody
        10.1.6    Immune Checkpoint Proteins
        10.1.7    Recombinant Regulatory Proteins
        10.1.8    Others
    10.2    Asia Pacific Recombinant Protein Market (2017-2032) by Application
        10.2.1    Market Overview
        10.2.2    Therapeutic
        10.2.3    Research
        10.2.4    Biotechnology Industry
    10.3    Asia Pacific Recombinant Protein Market (2017-2032) by Country
        10.3.1    China
        10.3.2    Japan
        10.3.3    India
        10.3.4    ASEAN
        10.3.5    Australia
        10.3.6    Others
11    Latin America Recombinant Protein Market (2017-2032)
    11.1     Latin America Recombinant Protein Market (2017-2032) by Product Type
        11.1.1    Market Overview
        11.1.2    Growth Factor and Cytokines
        11.1.3    Hormone
        11.1.4    Enzyme
        11.1.5    Antibody
        11.1.6    Immune Checkpoint Proteins
        11.1.7    Recombinant Regulatory Proteins
        11.1.8    Others
    11.2    Latin America Recombinant Protein Market (2017-2032) by Application
        11.2.1    Market Overview
        11.2.2    Therapeutic
        11.2.3     Research
        11.2.4    Biotechnology Industry
    11.3     Latin America Recombinant Protein Market (2017-2032) by Country
        11.3.1    Brazil
        11.3.2    Argentina
        11.3.3    Mexico
        11.3.4    Others
12    Middle East and Africa Recombinant Protein Market (2017-2032)
    12.1    Middle East and Africa Recombinant Protein Market (2017-2032) by Product Type
        12.1.1    Market Overview
        12.1.2    Growth Factor and Cytokines
        12.1.3    Hormone
        12.1.4    Enzyme
        12.1.5    Antibody
        12.1.6    Immune Checkpoint Proteins
        12.1.7    Recombinant Regulatory Proteins
        12.1.8    Others
    12.2    Middle East and Africa Recombinant Protein Market (2017-2032) by Application
        12.2.1    Market Overview
        12.2.2    Therapeutic
        12.2.3    Research
        12.2.4    Biotechnology Industry
    12.3    Middle East and Africa Recombinant Protein Market (2017-2032) by Country
        12.3.1    Saudi Arabia
        12.3.2    United Arab Emirates
        12.3.3    Nigeria
        12.3.4    South Africa
        12.3.5    Others
13    Regulatory Framework
    13.1    Regulatory Overview
    13.2    US FDA
    13.3    EU EMA
    13.4    INDIA CDSCO
    13.5    JAPAN PMDA
    13.6    Others
14    Patent Analysis
    14.1     Analysis by Type of Patent
    14.2     Analysis by Publication Year
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Patent Age
    14.5     Analysis by CPC Analysis
    14.6     Analysis by Patent Valuation 
    14.7     Analysis by Key Players
15    Clinical Trial Analysis
    15.1    Analysis by Trial Registration Year
    15.2    Analysis by Trial Status
    15.3    Analysis by Trial Phase
    15.4    Analysis by Therapeutic Area
    15.5    Analysis by Geography
16    Grant Analysis
    16.1    Analysis by Year
    16.2    Analysis by Amount Awarded
    16.3    Analysis by Issuing Authority
    16.4    Analysis by Grant Product
    16.5    Analysis by Funding Institute
    16.6    Analysis by Departments
    16.7    Analysis by Recipient Organization
17    Funding and Investment Analysis
    17.1     Analysis by Funding Instances
    17.2     Analysis by Type of Funding
    17.3     Analysis by Funding Amount
    17.4     Analysis by Leading Players
    17.5     Analysis by Leading Investors
    17.6     Analysis by Geography
18    Strategic Initiative
    18.1     Analysis by Partnership Instances
    18.2     Analysis by Type of Partnership
    18.3     Analysis by Leading Players
    18.4     Analysis by Geography
19    Supplier  Landscape
    19.1    Market Share Analysis, By Region (Top 5 Companies)
        19.1.1    Market Share Analysis: Global
        19.1.2    Market Share Analysis: North America
        19.1.3    Market Share Analysis: Europe
        19.1.4    Market Share Analysis: Asia-Pacific
        19.1.5    Market Share Analysis: Others
    19.2    Abbott  
        19.2.1    Financial Analysis
        19.2.2    Product Portfolio
        19.2.3    Demographic Reach and Achievements
        19.2.4    Mergers and Acquisitions
        19.2.5    Certifications 
    19.3    Abcam PLC 
        19.3.1    Financial Analysis
        19.3.2    Product Portfolio
        19.3.3    Demographic Reach and Achievements
        19.3.4    Mergers and Acquisitions
        19.3.5    Certifications
    19.4    Thermo Fisher Scientific, Inc . 
        19.4.1    Financial Analysis
        19.4.2    Product Portfolio
        19.4.3    Demographic Reach and Achievements
        19.4.4    Mergers and Acquisitions
        19.4.5    Certifications
    19.5    Bio-Techne Corp .
        19.5.1    Financial Analysis
        19.5.2    Product Portfolio
        19.5.3    Demographic Reach and Achievements
        19.5.4    Mergers and Acquisitions
        19.5.5    Certifications
    19.6    Merck KGaA 
        19.6.1    Financial Analysis
        19.6.2    Product Portfolio
        19.6.3    Demographic Reach and Achievements
        19.6.4    Mergers and Acquisitions
        19.6.5    Certifications
    19.7    Bio-Rad Laboratories, Inc .
        19.7.1    Financial Analysis
        19.7.2    Product Portfolio
        19.7.3    Demographic Reach and Achievements
        19.7.4    Mergers and Acquisitions
        19.7.5    Certifications
    19.8    GeneTex, Inc 
        19.8.1    Financial Analysis
        19.8.2    Product Portfolio
        19.8.3    Demographic Reach and Achievements
        19.8.4    Mergers and Acquisitions
        19.8.5    Certifications
    19.9    Lonza Group SA 
        19.9.1    Financial Analysis
        19.9.2    Product Portfolio
        19.9.3    Demographic Reach and Achievements
        19.9.4    Mergers and Acquisitions
        19.9.5    Certifications 
    19.10    F. Hoffmann-La Roche Ltd .
        19.10.1    Financial Analysis
        19.10.2    Product Portfolio
        19.10.3    Demographic Reach and Achievements
        19.10.4    Mergers and Acquisitions
        19.10.5    Certifications 
    19.11    PerkinElmer Inc .
        19.11.1    Financial Analysis
        19.11.2    Product Portfolio
        19.11.3    Demographic
        19.11.4    Mergers and Acquisitions
        19.11.5    Certifications
    19.12    Sino Biological Inc . 
        19.12.1    Financial Analysis
        19.12.2    Product Portfolio
        19.12.3    Demographic Reach and Achievements
        19.12.4    Mergers and Acquisitions
        19.12.5    Certifications 
    19.13    TAKARA HOLDINGS INC . 
        19.13.1    Financial Analysis
        19.13.2    Product Portfolio
        19.13.3    Demographic Reach and Achievements
        19.13.4    Mergers and Acquisitions
        19.13.5    Certifications
    19.14    Tosoh Corporation 
        19.14.1    Financial Analysis
        19.14.2    Product Portfolio
        19.14.3    Demographic Reach and Achievements
        19.14.4    Mergers and Acquisitions
        19.14.5    Certifications
    19.15    XENOTECH AI Pvt Ltd .
        19.15.1    Financial Analysis
        19.15.2    Product Portfolio
        19.15.3    Demographic Reach and Achievements
        19.15.4    Mergers and Acquisitions
        19.15.5    Certifications
    19.16    NEW ENGLAND BIOLABS, INC 
        19.16.1    Financial Analysis
        19.16.2    Product Portfolio
        19.16.3    Demographic Reach and Achievements
        19.16.4    Mergers and Acquisitions
        19.16.5    Certifications 
20    Recombinant Protein Market – Distribution Model (Additional Insight)
    20.1     Overview 
    20.2     Potential Distributors 
    20.3     Key Parameters for Distribution Partner Assessment 

21    Key Opinion Leaders (KOL) Insights (Additional Insight)

 

*Additional insights provided are customisable as per client requirements.

 

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.


**The supplier list is not exhaustive, moreover we can provide analysis of companies as per custom request.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER